FeaturedGeneticsNeuroscience·April 22, 2020·4 min readUsing ‘elite’ antibodies from COVID-19 survivors to develop potent therapiesResearchers are sifting through millions of antibodies produced by those who have recovered from COVID-19 to find which ones neutralize the virus. The team has already identified several antibodies that block coronavirus from interacting with its receptors.Read More